Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atacicept in Lupus Nephritis (APRIL-LN)
NCT00573157Phase 3Terminated
- Sponsor
- EMD Serono
- Start
- Dec 2007
- Primary completion
- Apr 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 5
01
Overview
A Phase 3 trial of atacicept in lupus nephritis (LN), sponsored by EMD Serono. Started Dec 2007; status: terminated.
02
Drugs
atacicept
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00573157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00573157.